APL Healthcare Ltd updates on inspection

The Prequalification Unit Inspection Team (PQT-INS) of World Health organization (WHO) had conducted an inspection at the Unit IV, a Formulation manufacturing facility, of APL Healthcare Limited, a wholly owned subsidiary of the Company, situated at Menakuru Village, Naidupeta Mandal, Tirupati District, Andhra Pradesh, from September 11 to September 15, 2023.

Based on the inspection findings and our response to the same, the PQT-INS has decided to recommend to the Prequalification Assessment Team that the above facility be named as a manufacturing site in the dossier for Dolutegravir, Lamivudine, Tenofovir Disoproxil Fumarate Tablets (50/300/300 mg).

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1044.30 as compared to the previous close of Rs. 1064.35. The total number of shares traded during the day was 44229 in over 2303 trades.

The stock hit an intraday high of Rs. 1085.40 and intraday low of 1038.60. The net turnover during the day was Rs. 46759895.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 WHO Inspection APLHealthcare Unit4 FormulationFacility